Please login to the form below

Not currently logged in
Email:
Password:

CAR-T

This page shows the latest CAR-T news and features for those working in and with pharma, biotech and healthcare.

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

Specifically, the facility will be used to support development of BioNTech’s pipeline of novel cell therapies, which includes cancer product candidates based on the company’s CAR-T cell amplifying ... Kite has already seen success with its own CAR T

Latest news

More from news
Approximately 55 fully matching, plus 167 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • The heavy toll of COVID-19 on cancer patients

    For example, all CAR-T cell therapies were paused as intensive care unit beds were needed to help COVID-19 patients recover. ... People who aren’t diagnosed with cancer as early as they might have been pre-pandemic, may not die for several years.

  • October 2020: diversity and inclusion in clinical trials round-up October 2020: diversity and inclusion in clinical trials round-up

    more — who don’t have the luxury to work from home, have groceries delivered, or socially isolate themselves; and those who depend on public transportation to get to work, and thus ... can’t travel safely in their car, or afford parking when they

  • In the precision medicine era, the line between products and services is blurred

    CAR-T is a new individualised cancer immunotherapy that has taken precision medicine to a new level. ... Both of these scenarios were true in the case of the CAR-T treatment.

  • The impossible launch

    SpaceX is inspiring people in a way that NASA hasn’t managed in over 30 years. ... Today’s therapy advances, such as CAR-T and gene therapy, are just as exciting and will help shape our world in the years to come.

  • Perspective: the patient edition

    The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.

More from PMHub
Approximately 4 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...